Effects of the irreversible acetylcholinesterase inhibitor soman on match-to-sample behavior of the juvenile baboon
Geller, I.; Hartmann, R.J.; Leal, B.Z.; Haines, R.J.; Gause, E.M.
Proceedings of the Western Pharmacology Society 27: 217-221
1984
ISSN/ISBN: 0083-8969 PMID: 6494157 Document Number: 223680
Document emailed within 1 workday
Related Documents
Filler, J.W. 1976: Modifying maternal teaching style: effects of task arrangement on the match-to-sample performance of retarded preschool-age-children American Journal of Mental Deficiency 80(6): 602-612Chrisopoulos, S.; Dollard, M.F.; Winefield, A.H.; Dormann, C. 2010: Increasing the probability of finding an interaction in work stress research: A two-wave longitudinal test of the triple-match principle : Match-making and match-breaking: Exploring the nature of match within and around job design Journal of Occupational and Organizational Psychology 83: 17-37
Kokka, N.; Clemons, G.K.; Lomax, P. 1987: Effects of the organophosphate cholinesterase inhibitor (DFP) on hypothalamic acetylcholinesterase and pituitary-adrenal activity Proceedings of the Western Pharmacology Society 30: 219-221
Hirai, K.; Kato, K.; Nakayama, T.; Hayako, H.; Ishihara, Y.; Goto, G.; Miyamoto, M. 1997: Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-b enzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats Journal of Pharmacology and Experimental Therapeutics 280(3): 1261-1269
Carr, C.; Bild, G.S.; Chang, A.C.; Peer, G.T.; Palmier, M.O.; Frazier, R.B.; Gustafson, M.E.; Wun, T.C.; Creasey, A.A.; Hinshaw, L.B. 1994: Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock Circulatory Shock 44(3): 126-137
Slotkin, T.A.; Seidler, F.J.; Trepanier, P.A.; Whitmore, W.L.; Lerea, L.; Barnes, G.A.; Weigel, S.J.; Bartolome, J. 1982: Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase Journal of Pharmacology and Experimental Therapeutics 222(3): 741-745
Zhu, Y.; Tong, X.-Y.; Zhao, Y.; Chen, H.; Jiang, F.-C. 2008: Construction of the pharmacophore model of acetylcholinesterase inhibitor Yao Xue Xue Bao 43(3): 267-276
Rao, K.S.; Aracava, Y.; Rickett, D.L.; Albuquerque, E.X. 1987: Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor Journal of Pharmacology and Experimental Therapeutics 240(1): 337-344
Magnier, V.; Flipon, E.; Godefroy, O.; Ganry, O.; Dupuy-Sonntag, D.; Rosa, A. 2005: Acetylcholinesterase inhibitor treatment for Alzheimer's disease: the experience in Picardy Revue Neurologique (Paris) 161(2): 211-213
Van Hooff, J.P.; van Es, A.; Persijn, G.G.; van Hooff-Eykenboom, I.J.; Kalff, M.W.; van Rood, J.J.; de Graeff, J. 1979: Cadaveric graft survival, clinical course, blood transfusion, HLA (A and B) match, and DR match in adult patients transplanted in one centre Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 16: 359-365
Prakash, N.J.; Schechter, P.J.; Grove, J.; Koch-Weser, J. 1978: Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice Cancer Research 38(9): 3059-3062
Vellas, B.; Lauque, S.; Gillette-Guyonnet, S.; Andrieu, S.; Cortes, F.; Nourhashémi, F.; Cantet, C.; Ousset, P.J.; Grandjean, H. 2005: Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment Journal of Nutrition Health and Aging 9(2): 75-80
Carpentier, P.; Foquin-Tarricone, A.; Bodjarian, N.; Rondouin, G.; Lerner-Natoli, M.; Kamenka, J.M.; Blanchet, G.; Denoyer, M.; Lallement, G. 1994: Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning Neurotoxicology 15(4): 837-851
Nieminen, S.A.; Lecklin, A.; Heikkinen, O.; Ylitalo, P. 1990: Acute behavioural effects of the organophosphates sarin and soman in rats Pharmacology and Toxicology 67(1): 36-40
Ligny, G.; Manouiloff, J.; Squifflet, N.; Goossens, R. 1970: Chronic effect of an acetylcholinesterase inhibitor on clinical disorders and posthistaminic gastric secretion in hypochlorhydria patients Acta Gastro-Enterologica Belgica 33(12): 893-900
Ogura, H.; Kosasa, T.; Kuriya, Y.; Yamanishi, Y. 2000: Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats Methods and Findings in Experimental and Clinical Pharmacology 22(2): 89-95
Dow, J.; Dulery, B.D.; Hornsperger, J.M.; Di Francesco, G.F.; Keshary, P.; Haegele, K.D. 1995: Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery Arzneimittel-Forschung 45(12): 1245-1252
Turon-Estrada, A.; López-Pousa, S.; Gelada-Batlle, E.; Garre-Olmo, J.; Lozano-Gallego, M.; Hernández-Ferràndiz, M.; Fajardo-Tibau, C.; Morante-Muñoz, V.; Vilalta-Franch, J. 2003: Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period Revista de Neurologia 36(5): 421-424
Imam, HME. 2000: Some morphological studies on the spleen and its arterial segmentation in baboon monkey (hamadryas baboon) Assiut Veterinary Medical Journal 438(5): 1-12
William, T.B.; Robert, S. Justin, S.B. 2012: The effects of small sample size and sample bias on threshold selection and accuracy assessment of species distribution models Ecography 35(3): 250-258